AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] Dr. Reddy's Laboratories Limited American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

LifeVantage Corporation (LFVN) Chief Marketing Officer Julie Boyster filed a Form 4 covering transactions on 1 July 2025.

  • 3,667 shares acquired through the conversion (code M) of previously granted performance restricted stock units (PSUs) at a $0 exercise price.
  • 3,970 shares disposed (code F) to cover statutory tax withholding at $13.39 per share.
  • Post-transaction, Boyster directly owns 115,214 common shares; all PSUs from the 2022 grant have now been converted.
  • The 2022 PSU grant paid out at 133.13 % of target, indicating the company exceeded the preset performance criteria.

The net effect is a modest reduction of 303 shares (-0.3 % of her holdings). Because both events are routine vesting and tax-withholding activities, they carry limited market impact but do confirm above-target performance achievement for the FY-2022 incentive metrics.

Julie Boyster, Chief Marketing Officer di LifeVantage Corporation (LFVN), ha presentato un Modulo 4 relativo a transazioni effettuate il 1° luglio 2025.

  • 3.667 azioni acquisite tramite conversione (codice M) di unità azionarie vincolate (PSU) precedentemente assegnate, con un prezzo di esercizio pari a 0 $.
  • 3.970 azioni cedute (codice F) per coprire la ritenuta fiscale obbligatoria, al prezzo di 13,39 $ per azione.
  • Dopo le operazioni, Boyster possiede direttamente 115.214 azioni ordinarie; tutte le PSU assegnate nel 2022 sono state convertite.
  • La concessione PSU del 2022 è stata liquidata al 133,13% dell’obiettivo, segnalando che la società ha superato i criteri di performance prefissati.

L’effetto netto è una lieve riduzione di 303 azioni (-0,3% del suo patrimonio azionario). Poiché entrambe le operazioni sono attività ordinarie di maturazione e ritenuta fiscale, hanno un impatto limitato sul mercato ma confermano il raggiungimento di performance superiori agli obiettivi per gli incentivi dell’anno fiscale 2022.

Julie Boyster, Directora de Marketing de LifeVantage Corporation (LFVN), presentó un Formulario 4 que cubre transacciones realizadas el 1 de julio de 2025.

  • 3,667 acciones adquiridas mediante la conversión (código M) de unidades de acciones restringidas por desempeño (PSU) previamente otorgadas, con un precio de ejercicio de 0 $.
  • 3,970 acciones vendidas (código F) para cubrir la retención fiscal obligatoria, a 13,39 $ por acción.
  • Después de la transacción, Boyster posee directamente 115,214 acciones ordinarias; todas las PSU otorgadas en 2022 han sido convertidas.
  • La concesión de PSU de 2022 se pagó al 133,13% del objetivo, lo que indica que la compañía superó los criterios de desempeño establecidos.

El efecto neto es una reducción modesta de 303 acciones (-0,3% de sus participaciones). Dado que ambos eventos son actividades rutinarias de adquisición y retención fiscal, tienen un impacto limitado en el mercado, pero confirman el logro de un desempeño superior al objetivo para los incentivos del año fiscal 2022.

LifeVantage Corporation(LFVN)ì� 최고 마케íŒ� ì±…ìž„ìž� Julie Boysterê°€ 2025ë…� 7ì›� 1ì� 거래 ë‚´ì—­ì� í¬í•¨í•� Form 4ë¥� 제출했습니다.

  • 3,667ì£� ì·¨ë“ (코드 M) ì´ì „ì—� ë¶€ì—¬ëœ ì„±ê³¼ 제한 ì£¼ì‹ ë‹¨ìœ„(PSU)ë¥� 전환하여 행사가ê²� 0달러ë¡� ì·¨ë“했습니다.
  • 3,970ì£� 처분 (코드 F) 법정 세금 ì›ì²œì§•수ë¥� 위해 주당 13.39달러ì—� 처분했습니다.
  • 거래 í›� BoysterëŠ� ì§ì ‘ 115,214ì£� 보통ì£�ë¥� 보유하며, 2022ë…� ë¶€ì—¬ëœ ëª¨ë“  PSUê°€ 전환ë˜ì—ˆìŠµë‹ˆë‹�.
  • 2022ë…� PSU 부여는 목표 대ë¹� 133.13%ë¡� 지급ë˜ì–� 회사가 사전ì—� 설정ë� 성과 기준ì� 초과했ìŒì� 나타냅니ë‹�.

순효과는 보유 주ì‹ì� 0.3%ì—� 해당하는 303주가 ì†Œí­ ê°ì†Œí•� 것입니다. ë‘� 거래 ëª¨ë‘ ì •ê¸°ì ì¸ 권리 ì·¨ë“ ë°� 세금 ì›ì²œì§•수 활ë™ìœ¼ë¡œ 시장ì—� 미치ëŠ� ì˜í–¥ì€ 제한ì ì´ì§€ë§� 2022 íšŒê³„ì—°ë„ ì¸ì„¼í‹°ë¸Œ 지표ì—ì„� 목표ë¥� 초과 달성했ìŒì� 확ì¸ì‹œì¼œì¤ë‹ˆë‹�.

Julie Boyster, Directrice Marketing de LifeVantage Corporation (LFVN), a déposé un formulaire 4 couvrant des transactions du 1er juillet 2025.

  • 3 667 actions acquises via la conversion (code M) d’unités d’actions restreintes de performance (PSU) précédemment attribuées, à un prix d’exercice de 0 $.
  • 3 970 actions cédées (code F) pour couvrir la retenue fiscale légale, au prix de 13,39 $ par action.
  • Après la transaction, Boyster détient directement 115 214 actions ordinaires ; toutes les PSU attribuées en 2022 ont été converties.
  • La distribution des PSU de 2022 a été effectuée à 133,13 % de l’objectif, indiquant que la société a dépassé les critères de performance fixés.

L’effet net est une légère réduction de 303 actions (-0,3 % de ses avoirs). Comme ces deux opérations sont des activités courantes de levée de droits et de retenue fiscale, elles ont un impact limité sur le marché mais confirment la réalisation d’une performance au-delà des objectifs pour les indicateurs d’incitation de l’exercice 2022.

Julie Boyster, Chief Marketing Officer der LifeVantage Corporation (LFVN), reichte ein Formular 4 ein, das Transaktionen vom 1. Juli 2025 abdeckt.

  • 3.667 Aktien erworben durch die Umwandlung (Code M) zuvor gewährter leistungsgebundener Restricted Stock Units (PSUs) zu einem Ausübungspreis von 0 $.
  • 3.970 Aktien veräußert (Code F) zur Deckung der gesetzlichen Steuerabzüge zu 13,39 $ je Aktie.
  • Nach der Transaktion besitzt Boyster direkt 115.214 Stammaktien; alle PSUs aus der Zuteilung 2022 wurden nun umgewandelt.
  • Die PSU-Zuteilung 2022 wurde mit 133,13 % des Ziels ausgezahlt, was darauf hinweist, dass das Unternehmen die vorgegebenen Leistungsziele übertroffen hat.

Der Nettoeffekt ist eine geringe Reduzierung von 303 Aktien (-0,3 % ihres Bestands). Da beide Vorgänge routinemäßige Vesting- und Steuerabzugsaktivitäten sind, haben sie nur begrenzte Auswirkungen auf den Markt, bestätigen jedoch die über dem Ziel liegende Leistungserreichung für die Anreizkennzahlen des Geschäftsjahres 2022.

Positive
  • Performance goals exceeded: 2022 PSU payout at 133.13 % of target confirms above-target achievement of preset financial criteria.
Negative
  • Minor net share reduction: Insider’s direct holdings decreased by 303 shares after tax withholding, though the change is immaterial.

Insights

TL;DR Routine PSU vesting; company beat performance hurdles; negligible change in insider ownership and minimal market impact.

The Form 4 shows standard quarterly vesting of 2022 PSUs. Conversion of 3,667 units at no cost and immediate share withholding of 3,970 shares for taxes reduced Boyster’s direct stake by only 303 shares, leaving her with 115,214 shares. The standout detail is that the 2022 award vested at 133.13 % of target, confirming that LifeVantage surpassed the financial KPIs embedded in that plan. While a positive signal on prior-period performance execution, the transaction is administrative and does not introduce new forward-looking information. I view the filing as neutral to the share price outlook.

Julie Boyster, Chief Marketing Officer di LifeVantage Corporation (LFVN), ha presentato un Modulo 4 relativo a transazioni effettuate il 1° luglio 2025.

  • 3.667 azioni acquisite tramite conversione (codice M) di unità azionarie vincolate (PSU) precedentemente assegnate, con un prezzo di esercizio pari a 0 $.
  • 3.970 azioni cedute (codice F) per coprire la ritenuta fiscale obbligatoria, al prezzo di 13,39 $ per azione.
  • Dopo le operazioni, Boyster possiede direttamente 115.214 azioni ordinarie; tutte le PSU assegnate nel 2022 sono state convertite.
  • La concessione PSU del 2022 è stata liquidata al 133,13% dell’obiettivo, segnalando che la società ha superato i criteri di performance prefissati.

L’effetto netto è una lieve riduzione di 303 azioni (-0,3% del suo patrimonio azionario). Poiché entrambe le operazioni sono attività ordinarie di maturazione e ritenuta fiscale, hanno un impatto limitato sul mercato ma confermano il raggiungimento di performance superiori agli obiettivi per gli incentivi dell’anno fiscale 2022.

Julie Boyster, Directora de Marketing de LifeVantage Corporation (LFVN), presentó un Formulario 4 que cubre transacciones realizadas el 1 de julio de 2025.

  • 3,667 acciones adquiridas mediante la conversión (código M) de unidades de acciones restringidas por desempeño (PSU) previamente otorgadas, con un precio de ejercicio de 0 $.
  • 3,970 acciones vendidas (código F) para cubrir la retención fiscal obligatoria, a 13,39 $ por acción.
  • Después de la transacción, Boyster posee directamente 115,214 acciones ordinarias; todas las PSU otorgadas en 2022 han sido convertidas.
  • La concesión de PSU de 2022 se pagó al 133,13% del objetivo, lo que indica que la compañía superó los criterios de desempeño establecidos.

El efecto neto es una reducción modesta de 303 acciones (-0,3% de sus participaciones). Dado que ambos eventos son actividades rutinarias de adquisición y retención fiscal, tienen un impacto limitado en el mercado, pero confirman el logro de un desempeño superior al objetivo para los incentivos del año fiscal 2022.

LifeVantage Corporation(LFVN)ì� 최고 마케íŒ� ì±…ìž„ìž� Julie Boysterê°€ 2025ë…� 7ì›� 1ì� 거래 ë‚´ì—­ì� í¬í•¨í•� Form 4ë¥� 제출했습니다.

  • 3,667ì£� ì·¨ë“ (코드 M) ì´ì „ì—� ë¶€ì—¬ëœ ì„±ê³¼ 제한 ì£¼ì‹ ë‹¨ìœ„(PSU)ë¥� 전환하여 행사가ê²� 0달러ë¡� ì·¨ë“했습니다.
  • 3,970ì£� 처분 (코드 F) 법정 세금 ì›ì²œì§•수ë¥� 위해 주당 13.39달러ì—� 처분했습니다.
  • 거래 í›� BoysterëŠ� ì§ì ‘ 115,214ì£� 보통ì£�ë¥� 보유하며, 2022ë…� ë¶€ì—¬ëœ ëª¨ë“  PSUê°€ 전환ë˜ì—ˆìŠµë‹ˆë‹�.
  • 2022ë…� PSU 부여는 목표 대ë¹� 133.13%ë¡� 지급ë˜ì–� 회사가 사전ì—� 설정ë� 성과 기준ì� 초과했ìŒì� 나타냅니ë‹�.

순효과는 보유 주ì‹ì� 0.3%ì—� 해당하는 303주가 ì†Œí­ ê°ì†Œí•� 것입니다. ë‘� 거래 ëª¨ë‘ ì •ê¸°ì ì¸ 권리 ì·¨ë“ ë°� 세금 ì›ì²œì§•수 활ë™ìœ¼ë¡œ 시장ì—� 미치ëŠ� ì˜í–¥ì€ 제한ì ì´ì§€ë§� 2022 íšŒê³„ì—°ë„ ì¸ì„¼í‹°ë¸Œ 지표ì—ì„� 목표ë¥� 초과 달성했ìŒì� 확ì¸ì‹œì¼œì¤ë‹ˆë‹�.

Julie Boyster, Directrice Marketing de LifeVantage Corporation (LFVN), a déposé un formulaire 4 couvrant des transactions du 1er juillet 2025.

  • 3 667 actions acquises via la conversion (code M) d’unités d’actions restreintes de performance (PSU) précédemment attribuées, à un prix d’exercice de 0 $.
  • 3 970 actions cédées (code F) pour couvrir la retenue fiscale légale, au prix de 13,39 $ par action.
  • Après la transaction, Boyster détient directement 115 214 actions ordinaires ; toutes les PSU attribuées en 2022 ont été converties.
  • La distribution des PSU de 2022 a été effectuée à 133,13 % de l’objectif, indiquant que la société a dépassé les critères de performance fixés.

L’effet net est une légère réduction de 303 actions (-0,3 % de ses avoirs). Comme ces deux opérations sont des activités courantes de levée de droits et de retenue fiscale, elles ont un impact limité sur le marché mais confirment la réalisation d’une performance au-delà des objectifs pour les indicateurs d’incitation de l’exercice 2022.

Julie Boyster, Chief Marketing Officer der LifeVantage Corporation (LFVN), reichte ein Formular 4 ein, das Transaktionen vom 1. Juli 2025 abdeckt.

  • 3.667 Aktien erworben durch die Umwandlung (Code M) zuvor gewährter leistungsgebundener Restricted Stock Units (PSUs) zu einem Ausübungspreis von 0 $.
  • 3.970 Aktien veräußert (Code F) zur Deckung der gesetzlichen Steuerabzüge zu 13,39 $ je Aktie.
  • Nach der Transaktion besitzt Boyster direkt 115.214 Stammaktien; alle PSUs aus der Zuteilung 2022 wurden nun umgewandelt.
  • Die PSU-Zuteilung 2022 wurde mit 133,13 % des Ziels ausgezahlt, was darauf hinweist, dass das Unternehmen die vorgegebenen Leistungsziele übertroffen hat.

Der Nettoeffekt ist eine geringe Reduzierung von 303 Aktien (-0,3 % ihres Bestands). Da beide Vorgänge routinemäßige Vesting- und Steuerabzugsaktivitäten sind, haben sie nur begrenzte Auswirkungen auf den Markt, bestätigen jedoch die über dem Ziel liegende Leistungserreichung für die Anreizkennzahlen des Geschäftsjahres 2022.

 

 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

June, 2025

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                                 Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

 

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

 

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                                 No x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 


 

 

EXHIBITS

 

Exhibit

Number

  

Description of Exhibits

 

 

 

99.1


Intimation dated June 14, 2025

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

 

 

 

Date: June 14, 2025

By:

/s/ K Randhir Singh

 

 

Name: K Randhir Singh

 

 

Title:   Company Secretary

 

 

3

 

 

FAQ

What insider activity did LFVN report on 1 July 2025?

The CMO converted 3,667 PSUs into shares and withheld 3,970 shares to cover taxes.

How many LifeVantage shares does Julie Boyster now own?

She directly owns 115,214 common shares after the reported transactions.

What was the vesting performance factor for the 2022 PSUs?

The PSUs vested at 133.13 % of the target based on achieved performance metrics.

Did the filing signal any new stock purchases by the insider?

No cash purchases were made; shares were acquired via PSU conversion and partly withheld for taxes.

Is this Form 4 likely to impact LFVN’s stock price?

The filing is routine and immaterial, so material price impact is unlikely.
Dr Reddys Labs

NYSE:RDY

RDY Rankings

RDY Latest News

RDY Latest SEC Filings

RDY Stock Data

12.15B
832.13M
15.04%
2.19%
Drug Manufacturers - Specialty & Generic
Healthcare
India
Hyderabad